EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $221,000 | -25.6% | 33,092 | -5.0% | 0.03% | -71.0% |
| Q2 2021 | $297,000 | -14.4% | 34,838 | -11.2% | 0.10% | -9.9% |
| Q1 2021 | $347,000 | -70.9% | 39,248 | -59.6% | 0.11% | -67.4% |
| Q4 2020 | $1,193,000 | +50.3% | 97,108 | -0.5% | 0.34% | +34.9% |
| Q3 2020 | $794,000 | -15.2% | 97,598 | +0.1% | 0.25% | -20.8% |
| Q2 2020 | $936,000 | +32.0% | 97,538 | -6.4% | 0.32% | +6.4% |
| Q1 2020 | $709,000 | -10.0% | 104,248 | +97.1% | 0.30% | +27.2% |
| Q4 2019 | $788,000 | +63.8% | 52,878 | +12.7% | 0.24% | +31.3% |
| Q3 2019 | $481,000 | +57.7% | 46,908 | +63.0% | 0.18% | +58.4% |
| Q2 2019 | $305,000 | +23.5% | 28,770 | +63.2% | 0.11% | -19.9% |
| Q1 2019 | $247,000 | -58.1% | 17,634 | -69.6% | 0.14% | -14.0% |
| Q4 2018 | $590,000 | -27.6% | 58,061 | -14.5% | 0.16% | -6.8% |
| Q3 2018 | $815,000 | +194.2% | 67,921 | +199.0% | 0.18% | +203.4% |
| Q2 2018 | $277,000 | – | 22,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 217,029 | $2,225,000 | 6.42% |
| Knoll Capital Management, LLC | 350,238 | $3,590,000 | 3.29% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $7,840,000 | 3.01% |
| Broadfin Capital, LLC | 1,367,377 | $14,016,000 | 2.59% |
| P.A.W. CAPITAL CORP | 200,000 | $2,050,000 | 2.56% |
| 683 Capital Management, LLC | 1,860,529 | $19,071,000 | 2.12% |
| EcoR1 Capital, LLC | 1,060,043 | $10,865,000 | 1.37% |
| MANGROVE PARTNERS IM, LLC | 847,284 | $8,685,000 | 1.05% |
| KNOTT DAVID M | 234,448 | $2,403,000 | 1.01% |
| Trellus Management Company, LLC | 85,000 | $871,000 | 0.87% |